Rucha Patil: I Had An Opportunity to Deliver a Lecture on A Topic Close to My Heart at EHA 2025
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared on LinkedIn:
‘‘MHG Mid-Term Conference 2025 and Essence of EHA 2025 An Update from the 18th ICML 2025 – Lugano on 19th Sept 2025 organized Perfect Square
I had the opportunity to deliver a lecture on “Evolving Dynamics of Laboratory Monitoring in Hemophilia with the Introduction of Novel Therapies” — a topic close to my heart as we continue to adapt to transformative changes in hemophilia care.
Great to reconnect and engage with colleagues from across the field — always a pleasure to share insights and learn together.
Now looking forward to the 49th Annual Conference of the Mumbai Hematology Group (MHG) and Essence of ASH, scheduled for 24th–26th January 2026.”
More from EHC 2025 featured in Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis